ilShinBioBase Co

ilShinBioBase Co Retained Earnings

The Retained Earnings of ilShinBioBase Co (068330.KQ) as of Nov 11, 2026 is 58.28 B KRW. In the previous year, Retained Earnings was 53.94 B KRW — a change of 8.06% (higher).

Retained Earnings

58.28 BKRW

YoY

8.06%

Last updated:

Retained Earnings of ilShinBioBase Co is 2025 58.28 B KRW. Retained Earnings of ilShinBioBase Co was 2024 53.94 B KRW. It decreases by 8.06% higher compared to the previous year.

The ilShinBioBase Co Retained Earnings history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Retained Earnings
Date
Retained Earnings
Jan 1, 2018
26.86 B KRW
Jan 1, 2019
31.30 B KRW
Jan 1, 2020
35.52 B KRW
Jan 1, 2021
41.61 B KRW
Jan 1, 2022
44.96 B KRW
Jan 1, 2023
50.55 B KRW
Jan 1, 2024
53.94 B KRW
Jan 1, 2025
58.28 B KRW
The ilShinBioBase Co Retained Earnings history
YEARRetained EarningsYoY
58.28 BKRW+8.06%
53.94 BKRW+6.70%
50.55 BKRW+12.44%
44.96 BKRW+8.06%
41.61 BKRW+17.14%
35.52 BKRW+13.48%
31.30 BKRW+16.55%
26.86 BKRW+13.21%
23.72 BKRW+10.41%
21.49 BKRW+14.37%
18.79 BKRW+10.69%
16.97 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ilShinBioBase Co Stock analysis

What does ilShinBioBase Co do? ilShinbiobase Co., Ltd. generates revenue by manufacturing and distributing industrial refrigeration equipment. Its product portfolio includes freeze dryers for drying sera, antibiotics, enzymes, laboratory samples, and foods; programmable freeze dryers for early-stage research with temperature, time, and vacuum control; deep freezers for biotechnology applications; and ice makers for research laboratories. The company also offers blood bank refrigerators, pharmaceutical refrigerators, shakers, and food processing equipment. These products are sold domestically and to overseas markets, targeting biotechnology firms, pharmaceutical companies, research institutions, and laboratories requiring specialized refrigeration solutions. The company's revenue streams primarily come from the sale of its industrial refrigeration equipment to customers in the biotechnology, pharmaceutical, and research sectors. Products like programmable freeze dryers and deep freezers are specifically designed for early-stage research and biotechnology applications, catering to the needs of laboratories and biotech firms. Blood bank refrigerators and pharmaceutical refrigerators serve healthcare and pharmaceutical industries, while ice makers and food processing equipment support research and food-related applications. ilShinbiobase’s business model focuses on providing specialized refrigeration equipment for niche markets. The company targets biotechnology and pharmaceutical industries with deep freezers and blood bank refrigerators, while programmable freeze dryers and shakers are marketed to research laboratories. Overseas and domestic distribution channels ensure market reach, with products tailored to specific industry requirements such as serum drying in pharmaceuticals and sample preservation in laboratories. ilShinBioBase Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ilShinBioBase Co stock

Retained Earnings of ilShinBioBase Co is 58.28 B KRW in 2025.

Retained Earnings of ilShinBioBase Co changed from 53.94 B KRW to 58.28 B KRW, representing a 8.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Retained Earnings ilShinBioBase Co since 2006 – with annual values, charts, and detailed analysis.

Retained earnings are the cumulative net income kept in the business rather than paid out as dividends. They fund future growth and operations.

Retained Earnings's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Retained Earnings's ilShinBioBase Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — ilShinBioBase Co

All Key Metrics — ilShinBioBase Co